GCP
CALC icon

GSA Capital Partners’s CalciMedica CALC Stock Holding History

GSA Capital Partners’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Sell
3,494
-1,261
-27% -$4.47K ﹤0.01% 1684
2026
Q1 		$13K Buy
+4,755
New +$48.2K ﹤0.01% 1650
2022
Q1 		– Sell
-1,231
Closed -$158K – 1435
2021
Q4 		$158K Buy
+1,231
New +$239K 0.02% 1264

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GSA Capital Partners's CALC Position: Q2 2026 in Review

GSA Capital Partners reduced its CalciMedica (CALC) stake by 27% in Q2 2026, selling an estimated $4.47K and leaving 3,494 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

GSA Capital Partners first reported a position in CALC in Q4 2021 and has held it in 3 quarters since. The position peaked at $158K in Q4 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • GSA Capital Partners held 3,494 shares of CalciMedica worth $18K as of Q2 2026.
  • GSA Capital Partners sold 1,261 CalciMedica shares in Q2 2026, an estimated $4.47K.
  • CalciMedica made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1684 holding.
  • GSA Capital Partners first reported a position in CalciMedica in Q4 2021 and has held it in 3 quarters since.
  • GSA Capital Partners's CalciMedica position peaked at $158K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.